EZH2 is involved in glioblastoma-induced immunosuppression, it induces IL-10 as well as TGF-β secretion in glioblastoma cells and attenuates microglia phagocytosis and shifts toward the M2 phenotype (69). Here, TGFB1 is linked to glioblastoma.